Nanotechnology-applied curcumin for different diseases therapy

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ghalandarlaki, Negar ^a   Alizadeh, Ali Mohammad ^a   Ashkani Esfahani, Soheil ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; CURCUMIN; CYCLODEXTRIN; DEMETHOXYCURCUMIN; DENDRIMER; DIDEMETHOXYCURCUMIN; GOLD NANOPARTICLE; LIPOSOME; NANOGELS; NANOPARTICLE; NIOSOME; POLYMER; SILVER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENCAPSULATION; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; MICELLE; NANOTECHNOLOGY; NONHUMAN; REVIEW; BIOAVAILABILITY; CHEMISTRY; NEOPLASMS;

ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CURCUMIN; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 84903650084     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/394264     Document Type: Review

References (141)

1. Jaruga E., Salvioli S., Dobrucki J., Chrul S., Bandorowicz-Pikuła J., Sikora E., Franceschi C., Cossarizza A., Bartosz G., Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Letters 1998 433 3 287 293 2-s2.0-0032555342 (Pubitemid 128369980)
2. Sreejayan S., Rao M. N. A., Curcuminoids as potent inhibitors of lipid peroxidation. Journal of Pharmacy and Pharmacology 1994 46 12 1013 1016 2-s2.0-0028587702
3. Ramsewak R. S., DeWitt D. L., Nair M. G., Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 2000 7 4 303 308 2-s2.0-0033862619 (Pubitemid 30618495)
4. Milobedzka J., Kostanecki S. V., Lampe V., Zur Kenntnis des Curcumins. Berichte der Deutschen Chemischen Gesellschaft 1910 43 2 2163 2170 10.1002/cber.191004302168
5. Ammon H. P., Wahl M. A., Pharmacology of Curcuma longa. Planta Medica 1991 57 1 1 7 2-s2.0-0026093041
6. Pandeya N. K., Old wives' tales: modern miracles-turmeric as traditional medicine in India. Trees for Life Journal 2005 1, article 3
7. Aggarwal B. B., Sung B., Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences 2009 30 2 85 94 2-s2.0-59349120231 10.1016/j.tips.2008. 11.002
8. Bharat B. A., Harikumar K. B., Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. International Journal of Biochemistry and Cell Biology 2009 41 1 40 59 2-s2.0-55949117806 10.1016/j.biocel.2008.06.010
9. Li L., Braiteh F. S., Kurzrock R., Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005 104 6 1322 1331 2-s2.0-24644508916 10.1002/cncr.21300 (Pubitemid 41282806)
10. Maiti K., Mukherjee K., Gantait A., Saha B. P., Mukherjee P. K., Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. International Journal of Pharmaceutics 2007 330 1-2 155 163 2-s2.0-33846234714 10.1016/j.ijpharm.2006.09.025 (Pubitemid 46097368)
11. Lin L., Shi Q., Nyarko A. K., Bastow K. F., Wu C.-C., Su C.-Y., Shih C. C.-Y., Lee K.-H., Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. Journal of Medicinal Chemistry 2006 49 13 3963 3972 2-s2.0-33745642485 10.1021/jm051043z (Pubitemid 43970710)
12. Ohtsu H., Xiao Z., Ishida J., Nagai M., Wang H.-K., Itokawa H., Su C.-Y., Shih C., Chiang T., Chang E., Lee Y., Tsai M.-Y., Chang C., Lee K.-H., Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. Journal of Medicinal Chemistry 2002 45 23 5037 5042 2-s2.0-0037038324 10.1021/jm020200g (Pubitemid 35278699)
13. Adams B. K., Ferstl E. M., Davis M. C., Herold M., Kurtkaya S., Camalier R. F., Hollingshead M. G., Kaur G., Sausville E. A., Rickles F. R., Snyder J. P., Liotta D. C., Shoji M., Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorganic and Medicinal Chemistry 2004 12 14 3871 3883 2-s2.0-2942726181 10.1016/j.bmc.2004. 05.006 (Pubitemid 38798249)
14. Benassi R., Ferrari E., Grandi R., Lazzari S., Saladini M., Synthesis and characterization of new β -diketo derivatives with iron chelating ability. Journal of Inorganic Biochemistry 2007 101 2 203 213 2-s2.0-33846104267 10.1016/j.jinorgbio.2006.09.020 (Pubitemid 46074150)
15. Shankar T. N., Shantha N. V., Ramesh H. P., Murthy I. A., Murthy V. S., Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs & monkeys. Indian Journal of Experimental Biology 1980 18 1 73 75 2-s2.0-0018891247 (Pubitemid 10143537)
16. Soni K. B., Kuttan R., Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian Journal of Physiology and Pharmacology 1992 36 4 273 275 2-s2.0-0027080521 (Pubitemid 23031285)
17. Anand P., Kunnumakkara A. B., Newman R. A., Aggarwal B. B., Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics 2007 4 6 807 818 2-s2.0-37549051274 10.1021/mp700113r
18. Sharma R. A., Steward W. P., Gescher A. J., Pharmacokinetics and pharmacodynamics of curcumin. Advances in Experimental Medicine and Biology 2007 595 453 470 2-s2.0-34347207227 10.1007/978-0-387-46401-5-20
19. Yang R., Zhang S., Kong D., Gao X., Zhao Y., Wang Z., Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharmaceutical Research 2012 29 12 3512 3525 10.1007/s11095-012-0848-8
20. Wahlstrom B., Blennow G., A study on the fate of curcumin in the rat. Acta Pharmacologica et Toxicologica 1978 43 2 86 92 2-s2.0-0018146189 (Pubitemid 9016316)
21. López-Lázaro M., Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Molecular Nutrition and Food Research 2008 52 1 S103 S127 2-s2.0-53449094405 10.1002/mnfr.200700238
22. Kasim N. A., Whitehouse M., Ramachandran C., Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Molecular Pharmaceutics 2004 1 1 85 96 10.1021/mp034006h
23. Pan M.-H., Huang T.-M., Lin J.-K., Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition 1999 27 4 486 494 2-s2.0-0032926620 (Pubitemid 29177642)
24. Payton F., Sandusky P., Alworth W. L., NMR study of the solution structure of curcumin. Journal of Natural Products 2007 70 2 143 146 2-s2.0-33947429094 10.1021/np060263s (Pubitemid 46447622)
25. Ishida J., Ohtsu H., Tachibana Y., Nakanishi Y., Bastow K. F., Nagai M., Wang H.-K., Itokawa H., Lee K.-H., Antitumor agents-part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorganic and Medicinal Chemistry 2002 10 11 3481 3487 2-s2.0-0036836671 10.1016/S0968-0896(02)00249-3
26. Selvam C., Jachak S. M., Thilagavathi R., Chakraborti A. K., Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents. Bioorganic and Medicinal Chemistry Letters 2005 15 7 1793 1797 2-s2.0-15044362170 10.1016/j.bmcl.2005.02.039 (Pubitemid 40380734)
27. Sun A., Shoji M., Lu Y. J., Liotta D. C., Snyder J. P., Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. Journal of Medicinal Chemistry 2006 49 11 3153 3158 2-s2.0-33744815937 10.1021/jm051141k (Pubitemid 43830514)
28. Ohori H., Yamakoshi H., Tomizawa M., Shibuya M., Kakudo Y., Takahashi A., Takahashi S., Kato S., Suzuki T., Ishioka C., Iwabuchi Y., Shibata H., Synthesis and biolgical analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Molecular Cancer Therapeutics 2006 5 10 2563 2571 2-s2.0-33750489699 10.1158/1535-7163.MCT-06-0174 (Pubitemid 44650921)
29. Freitas R. A. Jr., What is nanomedicine? Nanomedicine: Nanotechnology, Biology, and Medicine 2005 1 1 2 9 2-s2.0-31344445440 10.1016/j.nano.2004.11.003 (Pubitemid 43963605)
30. Rahman S., Cao S., Steadman K. J., Wei M., Parekh H. S., Native and β -cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer. Drug Delivery 2012 19 7 346 353 10.3109/10717544.2012.721143
31. Shi H. S., Gao X., Li D., A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. International Journal of Nanomedicine 2012 7 2601 2611 10.2147/IJN.S31439
32. Matabudul D., Pucaj K., Bolger G., Vcelar B., Majeed M., Helson L., Tissue distribution of (Lipocurc) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogs. Anticancer Research 2012 32 10 4359 4364
33. Karewicz A., Bielska D., Gzyl-Malcher B., Kepczynski M., Lach R., Nowakowska M., Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloids and Surfaces B: Biointerfaces 2011 88 1 231 239 2-s2.0-80052096116 10.1016/j.colsurfb.2011.06.037
34. Dhule S. S., Penfornis P., Frazier T., Walker R., Feldman J., Tan G., He J., Alb A., John V., Pochampally R., Curcumin-loaded γ -cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine: Nanotechnology, Biology, and Medicine 2012 8 4 440 451 2-s2.0-84860229695 10.1016/j.nano.2011.07.011
35. Orr W. S., Denbo J. W., Saab K. R., Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition. Surgery 2012 151 5 736 744 10.1016/j.surg.2011.12.014
36. Wang D., Veena M. S., Stevenson K., Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clinical Cancer Research 2008 14 19 6228 6236 10.1158/1078-0432.CCR- 07-5177
37. Chen Y., Wu Q., Zhang Z., Yuan L., Liu X., Zhou L., Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 2012 17 5 5972 5987 10.3390/molecules17055972
38. Rogers N. M., Stephenson M. D., Kitching A. R., Horowitz J. D., Coates P. T. H., Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells. The British Journal of Pharmacology 2012 166 1 194 209 2-s2.0-84859720172 10.1111/j.1476-5381.2011.01590.x
39. Basnet P., Hussain H., Tho I., Skalko-Basnet N., Liposomal delivery system enhances anti-inflammatory properties of curcumin. Journal of Pharmaceutical Sciences 2012 101 2 598 609 2-s2.0-84455208306 10.1002/jps.22785
40. Raveendran R., Bhuvaneshwar G., Sharma C. P., In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells. Journal of Biomaterials Applications 2013 27 7 811 827 10.1177/0885328211427473
41. Yu H., Li J., Shi K., Huang Q., Structure of modified ε -polylysine micelles and their application in improving cellular antioxidant activity of curcuminoids. Food and Function 2011 2 7 373 380 2-s2.0-79961000206 10.1039/c1fo10053j
42. Podaralla S., Averineni R., Alqahtani M., Perumal O., Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin. Molecular Pharmaceutics 2012 9 9 2778 2786 10.1021/mp2006455
43. Song Z., Feng R., Sun M., Guo C., Gao Y., Li L., Zhai G., Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. Journal of Colloid and Interface Science 2011 354 1 116 123 2-s2.0-78650179595 10.1016/j.jcis.2010.10.024
44. Leung M. H. M., Colangelo H., Kee T. W., Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir 2008 24 11 5672 5675 2-s2.0-45749102576 10.1021/la800780w
45. Adhikary R., Carlson P. J., Kee T. W., Petrich J. W., Excited-state intramolecular hydrogen atom transfer of curcumin in surfactant micelles. Journal of Physical Chemistry B 2010 114 8 2997 3004 2-s2.0-77749344620 10.1021/jp9101527
46. Began G., Sudharshan E., Appu Rao A. G., Inhibition of lipoxygenase 1 by phosphatidylcholine micelles-bound curcumin. Lipids 1998 33 12 1223 1228 2-s2.0-0032405732 10.1007/s11745-998-0327-2 (Pubitemid 29061889)
47. Jain S., Singh P., Mishra V., Vyas S. P., Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunology Letters 2005 101 1 41 49 2-s2.0-24744448887 10.1016/j.imlet.2005.04. 002 (Pubitemid 41297497)
48. Mandal S., Banerjee C., Ghosh S., Kuchlyan J., Sarkar N., Modulation of the photophysical properties of curcumin in nonionic surfactant (Tween-20) forming micelles and niosomes: a comparative study of different microenvironments. Journal of Physical Chemistry B 2013 117 23 6957 6968 10.1021/jp403724g
49. Rungphanichkul N., Nimmannit U., Muangsiri W., Rojsitthisak P., Preparation of curcuminoid niosomes for enhancement of skin permeation. Pharmazie 2011 66 8 570 575 2-s2.0-80053302689 10.1691/ph.2011.1018
50. Tønnesen H. H., Másson M., Loftsson T., Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. International Journal of Pharmaceutics 2002 244 1-2 127 135 2-s2.0-0037026270 10.1016/S0378-5173(02)00323-X (Pubitemid 35245453)
51. Tomren M. A., Másson M., Loftsson T., Tønnesen H. H., Studies on curcumin and curcuminoids. XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. International Journal of Pharmaceutics 2007 338 1-2 27 34 2-s2.0-34248684129 10.1016/j.ijpharm.2007.01.013 (Pubitemid 46777212)
52. Darandale S. S., Vavia P. R., Cyclodextrin-based nanosponges of curcumin: formulation and physicochemical characterization. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2013 75 3-4 315 322 10.1007/s10847-012-0186- 9
53. Yadav V. R., Prasad S., Kannappan R., Ravindran J., Chaturvedi M. M., Vaahtera L., Parkkinen J., Aggarwal B. B., Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochemical Pharmacology 2010 80 7 1021 1032 2-s2.0-77955665447 10.1016/j.bcp.2010.06.022
54. Yadav V. R., Suresh S., Devi K., Yadav S., Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 2009 10 3 752 762 2-s2.0-70449520196 10.1208/s12249-009-9264-8
55. Yallapu M. M., Jaggi M., Chauhan S. C., β -cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids and Surfaces B: Biointerfaces 2010 79 1 113 125 2-s2.0-77952950459 10.1016/j.colsurfb.2010.03.039
56. Dandawate P. R., Vyas A., Ahmad A., Inclusion complex of novel curcumin analogue CDF and β -cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharmaceutical Research 2012 29 7 1775 1786 10.1007/s11095-012-0700-1
57. Debnath S., Saloum D., Dolai S., Sun C., Averick S., Raja K., Fata J.E., Dendrimer-curcumin conjugate: a water soluble and effective cytotoxic agent against breast cancer cell lines. Anti-Cancer Agents in Medicinal Chemistry 2013 13 10 1531 1539
58. Yallapu M. M., Ebeling M. C., Chauhan N., Jaggi M., Chauhan S. C., Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. International Journal of Nanomedicine 2011 6 2779 2790 2-s2.0-84858848548
59. Cao J., Zhang H., Wang Y., Yang J., Jiang F., Investigation on the interaction behavior between curcumin and PAMAM dendrimer by spectral and docking studies. Spectrochimica Acta A: Molecular and Biomolecular Spectroscopy 2013 108 251 255 10.1016/j.saa.2013.02.003
60. Mollazade M., Zarghami N., Nasiri M., Nejati K., Rahmati M., Pourhasan M., Polyamidoamine (PAMAM) encapsulated curcumin inhibits telomerase activity in breast cancer cell line. Clinical Biochemistry 2011 44 13, supplement S217 10.1016/j.clinbiochem.2011.08.966
61. Sarbolouki M. N., Alizadeh A. M., Khaniki M., Azizian S., Mohaghgheg M. A., Protective effect of dendrosomal curcumin combination on colon cancer in rat. Tehran University Medical Journal 2012 69 11 678 685 2-s2.0-84855475787
62. Alizadeh A. M., Khaniki M., Azizian S., Mohaghgheghi M. A., Sadeghizadeh M., Najafi F., Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier-curcumin. European Journal of Pharmacology 2012 689 1-3 226 232 10.1016/j.ejphar.2012.06.016
63. Babaei E., Sadeghizadeh M., Hassan Z. M., Feizi M. A. H., Najafi F., Hashemi S. M., Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo. International Immunopharmacology 2012 12 1 226 234 2-s2.0-84856110175 10.1016/j.intimp.2011.11.015
64. Mangalathillam S., Rejinold N. S., Nair A., Lakshmanan V.-K., Nair S. V., Jayakumar R., Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 2012 4 1 239 250 2-s2.0-83455219238 10.1039/c1nr11271f
65. Wei X., Senanayake T. H., Warren G., Vinogradov S. V., Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjugate Chemistry 2013 24 4 658 668 10.1021/bc300632w
66. Zhang J., Tang Q., Xu X., Li N., Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery. International Journal of Pharmaceutics 2013 448 1 168 174 10.1016/j.ijpharm. 2013.03.021
67. Akhtar F., Rizvi M. M. A., Kar S. K., Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnology Advances 2012 30 1 310 320 2-s2.0-84855746005 10.1016/j.biotechadv.2011.05.009
68. Li X., Chen S., Zhang B., In situ injectable nano-composite hydrogel composed of curcumin, N,O-carboxymethyl chitosan and oxidized alginate for wound healing application. International Journal of Pharmaceutics 2012 437 1-2 110 119 10.1016/j.ijpharm.2012.08.001
69. Yadav A., Lomash V., Samim M., Flora S. J., Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity. Chemico-Biological Interactions 2012 199 1 49 61 10.1016/j.cbi.2012.05.011
70. Shukla S. K., Mishra A. K., Arotiba O. A., Mamba B. B., Chitosan-based nanomaterials: a state-of-the-art review. International Journal of Biological Macromolecules 2013 59 46 58 10.1016/j.ijbiomac.2013.04.043
71. Karewicz A., Bielska D., Loboda A., Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives. Colloids and Surfaces B: Biointerfaces 2013 109 307 316 10.1016/j.colsurfb.2013.03.059
72. Singh D. K., Jagannathan R., Khandelwal P., Abraham P. M., Poddar P., In situ synthesis and surface functionalization of gold nanoparticles with curcumin and their antioxidant properties: an experimental and density functional theory investigation. Nanoscale 2013 5 5 1882 1893 10.1039/c2nr33776b
73. Moten A., The use of gold-citrate nanoparticles and curcumin nanomedicine to target cancer at a single cell level. Proceedings of the NSTI Nanotechnology Conference and Trade Show June 2008
74. Varaprasad K., Murali Mohan Y., Vimala K., Mohana Raju K., Synthesis and characterization of hydrogel-silver nanoparticle-curcumin composites for wound dressing and antibacterial application. Journal of Applied Polymer Science 2011 121 2 784 796 2-s2.0-79953714547 10.1002/app.33508
75. Zhou H., Wu X., Xu W., Yang J., Yang Q., Fluorescence enhancement of the silver nanoparticales-curcumin-cetyltrimethylammonium bromide-nucleic acids system and its analytical application. Journal of Fluorescence 2010 20 4 843 850 2-s2.0-77955661989 10.1007/s10895-010-0627-z
76. Ekambaram P., Abdul H. S., Formulation and evaluation of solid lipid nanoparticles of ramipril. Journal of Young Pharmacists 2011 3 3 216 220 2-s2.0-80051869434 10.4103/0975-1483.83765
77. Kakkar V., Singh S., Singla D., Kaur I. P., Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Molecular Nutrition and Food Research 2011 55 3 495 503 2-s2.0-79952143791 10.1002/mnfr.201000310
78. Kakkar V., Muppu S. K., Chopra K., Kaur I. P., Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. European Journal of Pharmaceutics and Biopharmaceutics 2013 85 3 339 345 10.1016/j.ejpb.2013.02.005
79. Yadav V. R., Suresh S., Devi K., Yadav S., Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease. Journal of Pharmacy and Pharmacology 2009 61 3 311 321 2-s2.0-64549137962 10.1211/jpp/61.03.0005
80. Wang W., Zhu R., Xie Q., Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. International Journal of Nanomedicine 2012 7 3667 3677 10.2147/IJN.S30428
81. Mulik R. S., Mönkkönen J., Juvonen R. O., Mahadik K. R., Paradkar A. R., Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. International Journal of Pharmaceutics 2010 398 1-2 190 203 2-s2.0-77956226273 10.1016/j.ijpharm.2010.07.021
82. Faraji A. H., Wipf P., Nanoparticles in cellular drug delivery. Bioorganic and Medicinal Chemistry 2009 17 8 2950 2962 2-s2.0-64049086772 10.1016/j.bmc.2009.02.043
83. Cho K., Wang X., Nie S., Chen Z., Shin D. M., Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Research 2008 14 5 1310 1316 2-s2.0-40949127319 10.1158/1078-0432.CCR-07-1441 (Pubitemid 351413909)
84. Aqil F., Munagala R., Jeyabalan J., Vadhanam M. V., Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Letters 2013 334 1 133 141 10.1016/j.canlet.2013.02.032
85. Chen C., Johnston T. D., Jeon H., Gedaly R., McHugh P. P., Burke T. G., Ranjan D., An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. International Journal of Pharmaceutics 2009 366 1-2 133 139 2-s2.0-57849106304 10.1016/j.ijpharm.2008.09.009
86. Pandelidou M., Dimas K., Georgopoulos A., Hatziantoniou S., Demetzos C., Preparation and characterization of lyophilised EGG PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines. Journal of Nanoscience and Nanotechnology 2011 11 2 1259 1266 2-s2.0-79954994405 10.1166/jnn.2011.3093
87. Sreekanth C. N., Bava S. V., Sreekumar E., Anto R. J., Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene 2011 30 28 3139 3152 2-s2.0-79960382286 10.1038/onc.2011.23
88. Mach C. M., Chen J. H., Mosley S. A., Kurzrock R., Smith J. A., Evaluation of liposomal curcumin cytochrome P450 metabolism. Anticancer Research 2010 30 3 811 814 2-s2.0-77951042580
89. Isacchi B., Bergonzi M. C., Grazioso M., Righeschi C., Pietretti A., Severini C., Bilia A. R., Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice. European Journal of Pharmaceutics and Biopharmaceutics 2012 80 3 528 534 2-s2.0-84858155431 10.1016/j.ejpb.2011.11.015
90. Agarwal N. B., Jain S., Nagpal D., Agarwal N. K., Mediratta P. K., Sharma K. K., Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundamental & Clinical Pharmacology 2013 27 2 169 172 10.1111/j.1472-8206.2011.01002.x
91. Cho H. K., Cheong I. W., Lee J. M., Kim J. H., Polymeric nanoparticles, micelles and polymersomes from amphiphilic block copolymer. Korean Journal of Chemical Engineering 2010 27 3 731 740 2-s2.0-77952295000 10.1007/s11814-010- 0216-5
92. Jones M.-C., Leroux J.-C., Polymeric micelles-a new generation of colloidal drug carriers. European Journal of Pharmaceutics and Biopharmaceutics 1999 48 2 101 111 2-s2.0-0032778659 10.1016/S0939-6411(99)00039-9 (Pubitemid 29401986)
93. Liu L., Sun L., Wu Q., Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. International Journal of Pharmaceutics 2013 443 1-2 175 182 10.1016/j.ijpharm.2012.12.032
94. Ma Z., Haddadi A., Molavi O., Lavasanifar A., Lai R., Samuel J., Micelles of poly(ethylene oxide)-b-poly(ε -caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. Journal of Biomedical Materials Research A 2008 86 2 300 310 2-s2.0-47049093012 10.1002/jbm.a.31584 (Pubitemid 351969628)
95. Zhao L., Du J., Duan Y., Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids and Surfaces B: Biointerfaces 2012 97 101 108 10.1016/j.colsurfb.2012. 04.017
96. Gou M., Men K., Shi H., Xiang M., Zhang J., Song J., Long J., Wan Y., Luo F., Zhao X., Qian Z., Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 2011 3 4 1558 1567 2-s2.0-79953739245 10.1039/c0nr00758g
97. Letchford K., Liggins R., Burt H., Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. Journal of Pharmaceutical Sciences 2008 97 3 1179 1190 2-s2.0-42949124511 10.1002/jps.21037
98. Dai F., Chen W.-F., Zhou B., Yang L., Liu Z.-L., Antioxidative effects of curcumin and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Phytotherapy Research 2009 23 9 1220 1228 2-s2.0-69749083984 10.1002/ptr.2517
99. Mondal S., Ghosh S., Role of curcumin on the determination of the critical micellar concentration by absorbance, fluorescence and fluorescence anisotropy techniques. Journal of Photochemistry and Photobiology B 2012 115 9 15 10.1016/j.jphotobiol.2012.06.004
100. Sahu A., Kasoju N., Goswami P., Bora U., Encapsulation of curcumin in Pluronic block copolymer micelles for drug delivery applications. Journal of Biomaterials Applications 2011 25 6 619 639 2-s2.0-79951611459 10.1177/0885328209357110
101. Yokoyama M., Clinical applications of polymeric micelle carrier systems in chemotherapy and Image diagnosis of solid tumors. Journal of Experimental and Clinical Medicine 2011 3 4 151 158 2-s2.0-80053051929 10.1016/j.jecm.2011.06. 002
102. Wang F., Wu X., Wang F., Liu S., Jia Z., Yang J., The sensitive fluorimetric method for the determination of curcumin using the enhancement of mixed micelle. Journal of Fluorescence 2006 16 1 53 59 2-s2.0-33645686405 10.1007/s10895-005-0025-0
103. Gong C., Deng S., Wu Q., Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 2013 34 4 1413 1432 10.1016/j.biomaterials.2012.10.068
104. Wang F., Huang W., Jiang L., Tang B., Quantitative determination of proteins based on strong fluorescence enhancement in curcumin-chitosan-proteins system. Journal of Fluorescence 2012 22 2 615 622 10.1007/s10895-011-0997-x
105. Mohanty C., Acharya S., Mohanty A. K., Dilnawaz F., Sahoo S. K., Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. Nanomedicine 2010 5 3 433 449 2-s2.0-77951218485 10.2217/nnm.10.9
106. Malhotra M., Jain N. K., Niosomes as drug carriers. Indian Drugs 1994 31 3 81 86 2-s2.0-0028200769 (Pubitemid 24176565)
107. Karim M., Mandal A., Biswas N., Guha A., Chatterjee S., Behera M., Kuotsu K., Niosome: a future of targeted drug delivery systems. Journal of Advanced Pharmaceutical Technology and Research 2010 1 4 374 380 2-s2.0-79952940021 10.4103/0110-5558.76435
108. Azmin M. N., Florence A. T., Handjani-Vila R. M., Stuart J. F., Vanlerberghe G., Whittaker J. S., The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice. Journal of Pharmacy and Pharmacology 1985 37 4 237 242 2-s2.0-0021909666 (Pubitemid 15149834)
109. Kumar K., Rai A. K., Development and evaluation of proniosome- encapsulated curcumin for transdermal administration. Tropical Journal of Pharmaceutical Research 2011 10 6 697 703 2-s2.0-83455163939
110. Menuel S., Joly J.-P., Courcot B., Elysée J., Ghermani N.-E., Marsura A., Synthesis and inclusion ability of a bis- β -cyclodextrin pseudo-cryptand towards Busulfan anticancer agent. Tetrahedron 2007 63 7 1706 1714 2-s2.0-33846214276 10.1016/j.tet.2006.10.070 (Pubitemid 46091797)
111. Davis M. E., Brewster M. E., Cyclodextrin-based pharmaceutics: past, present and future. Nature Reviews Drug Discovery 2004 3 12 1023 1035 2-s2.0-10444279209 10.1038/nrd1576 (Pubitemid 39642365)
112. Yallapu M. M., Jaggi M., Chauhan S. C., Poly(β -cyclodextrin)/ curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. Macromolecular Bioscience 2010 10 10 1141 1151 2-s2.0-77955854472 10.1002/mabi.201000084
113. Lomedasht F., Rami A., Zarghami N., Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Advanced Pharmaceutical Bulletin 2013 3 1 127 130 10.5681/apb.2013.021
114. Rocks N., Bekaert S., Coia I., Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. The British Journal of Cancer 2012 107 7 1083 1092 10.1038/bjc.2012.379
115. Agashe H., Sahoo K., Lagisetty P., Awasthi V., Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)- 4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats. Colloids and Surfaces B: Biointerfaces 2011 84 2 329 337 2-s2.0-79952814944 10.1016/j.colsurfb.2011.01.023
116. Namazi H., Adeli M., Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials 2005 26 10 1175 1183 2-s2.0-4644258898 10.1016/j.biomaterials.2004.04.014 (Pubitemid 39286827)
117. Longmire M., Choyke P. L., Kobayashi H., Dendrimer-based contrast agents for molecular imaging. Current Topics in Medicinal Chemistry 2008 8 14 1180 1186 2-s2.0-52949091530 10.2174/156802608785849021
118. Shi W., Dolai S., Rizk S., Hussain A., Tariq H., Averick S., L'Amoreaux W., El Idrissi A., Banerjee P., Raja K., Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications. Organic Letters 2007 9 26 5461 5464 2-s2.0-38349130550 10.1021/ol702370m
119. Markatou E., Gionis V., Chryssikos G. D., Hatziantoniou S., Georgopoulos A., Demetzos C., Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers. International Journal of Pharmaceutics 2007 339 1-2 231 236 2-s2.0-34347242772 10.1016/j.ijpharm.2007.02.037 (Pubitemid 46992764)
120. Khaniki M., Azizian S., Alizadeh A. M., Hemmati H., Emamipour N., Mohagheghi M. A., The antiproliferative and anticancerogenic effects of nano-curcumin in rat colon cancer. Tehran University Medical Journal 2013 71 5 277 284
121. Haririan I., Alavidjeh M. S., Khorramizadeh M. R., Ardestani M. S., Ghane Z. Z., Namazi H., Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines. International Journal of Nanomedicine 2010 2 5 63 75 2-s2.0-77951168942
122. Kabanov A. V., Vinogradov S. V., Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angewandte Chemie-International Edition 2009 48 30 5418 5429 2-s2.0-70349920791 10.1002/anie.200900441
123. Gonçalves C., Pereira P., Schellenberg P., Coutinho P., Gama F., Self-assembled dextrin nanogel as curcumin delivery system. Journal of Biomaterials and Nanobiotechnology 2012 3 2 178 184 10.4236/jbnb.2012.32024
124. Maya S., Sarmento B., Nair A., Rejnold N. S., Nair S. V., Jayakumar R., Smart stimuli sensitive nanogels in cancer drug delivery and imaging: a review. Current Pharmaceutical Design 2013 19 41 7203 7218
125. Wu W., Shen J., Banerjee P., Zhou S., Water-dispersible multifunctional hybrid nanogels for combined curcumin and photothermal therapy. Biomaterials 2011 32 2 598 609 2-s2.0-78449256873 10.1016/j.biomaterials.2010.08.112
126. Bernkop-Schnürch A., Dünnhaupt S., Chitosan-based drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 2012 81 3 463 469 10.1016/j.ejpb.2012.04.007
127. Mazzarino L., Travelet C., Ortega-Murillo S., Otsuka I., Pignot-Paintrand I., Lemos-Senna E., Borsali R., Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications. Journal of Colloid and Interface Science 2012 370 1 58 66 2-s2.0-84856540005 10.1016/j.jcis.2011.12.063
128. Das R. K., Kasoju N., Bora U., Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine: Nanotechnology, Biology, and Medicine 2010 6 1 153 160 2-s2.0-75149122722 10.1016/j.nano.2009.05.009
129. Rejinold N. S., Sreerekha P. R., Chennazhi K. P., Nair S. V., Jayakumar R., Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. International Journal of Biological Macromolecules 2011 49 2 161 172 2-s2.0-79957949188 10.1016/j.ijbiomac.2011.04.008
130. Kommareddy S., Tiwari S. B., Amiji M. M., Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technology in Cancer Research and Treatment 2005 4 6 615 625 2-s2.0-30544446478 (Pubitemid 43083345)
131. Duan J., Zhang Y., Han S., Chen Y., Li B., Liao M., Chen W., Deng X., Zhao J., Huang B., Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. International Journal of Pharmaceutics 2010 400 1-2 211 220 2-s2.0-77957678756 10.1016/j.ijpharm.2010.08.033
132. Omidfar K., Khorsand F., Darziani Azizi M., New analytical applications of gold nanoparticles as label in antibody based sensors. Biosensors and Bioelectronics 2013 43 336 347 10.1016/j.bios.2012.12.045
133. Rajesh J., Rajasekaran M., Rajagopal G., Athappan P., Analytical methods to determine the comparative DNA binding studies of curcumin-Cu(II) complexes. Spectrochimica Acta A: Molecular and Biomolecular Spectroscopy 2012 97 223 230 10.1016/j.saa.2012.05.006
134. Gangwar R., Dhumale V., Kumari D., Conjugation of curcumin with PVP capped gold nanoparticles for improving bioavailability. Materials Science and Engineering C 2012 32 8 2659 2663 10.1016/j.msec.2012.07.022
135. Kumar K., Gnanaprakash D., Mayilvaganan K., Arunraj C., Mohankumar S., Chitosan-gold nanoparticles as delivery systems for curcumins. International Journal of Pharmaceutical Sciences & Research 2012 3 11 4533
136. Manju S., Sreenivasan K., Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells. Journal of Colloid and Interface Science 2012 368 1 144 151 2-s2.0-84855856570 10.1016/j.jcis.2011.11.024
137. Sindhu K., Indra R., Rajaram A., Sreeram K. J., Rajaram R., Investigations on the interaction of gold-curcumin nanoparticles with human peripheral blood lymphocytes. Journal of Biomedical Nanotechnology 2011 7 1 56 2-s2.0-79957681727 10.1166/jbn.2011.1199
138. Sweet M. J., Singleton I., Silver nanoparticles: a microbial perspective. Advances in Applied Microbiology 2011 77 115 133 2-s2.0-80055121491 10.1016/B978-0-12-387044-5.00005-4
139. Ravindran A., Chandran P., Khan S. S., Biofunctionalized silver nanoparticles: advances and prospects. Colloids and Surfaces B: Biointerfaces 2013 105 342 352 10.1016/j.colsurfb.2012.07.036
140. Dadhaniya P., Patel C., Muchhara J., Bhadja N., Mathuria N., Vachhani K., Soni M. G., Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies. Food and Chemical Toxicology 2011 49 8 1834 1842 2-s2.0-79958762040 10.1016/j.fct.2011.05.001
141. Kakkar V., Kaur I. P., Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food and Chemical Toxicology 2011 49 11 2906 2913 2-s2.0-80052839510 10.1016/j.fct.2011.08.006